PAD Profile : Dalteparin sodium - VTE prevention post hip/knee replacement

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Dalteparin sodium - VTE prevention post hip/knee replacement

PAD Profile : Dalteparin sodium - VTE prevention post hip/knee replacement

Keywords :

VTE prophylaxis, venous thromboembolism, Low molecular weight heparins, LMWH, SWLEOC guidelines

Brand Names Include :

Fragmin

Traffic Light Status

Status 1 of 1.

Status :

Red

Formulations :

Subcutaneous injection (sc)

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

Comments :

No comments returned.

Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type

Document

Review Date

Guidelines (Local)

Venous Thromboembolism Prophylaxis - SWLEOC Guidelines - Feb 19

01 February 2020

Committee Recommendations

Date

Committee Name

Narrative

27 October 2010

Not Set

The use of LMWH to prevent VTE post operatively is considered as red on the traffic light system. The full course of treatment should be supplied by the Acute Trust.

Associated BNF Codes

02. Cardiovascular System

02.08.01. Parenteral anticoagulants